|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 171.10 EUR | -1.27% |
|
+0.41% | +37.76% |
| 07-14 | AURUBIS AG : Warburg Research reiterates its Buy rating | ZD |
| 07-10 | AURUBIS AG : Deutsche Bank reaffirms its Neutral rating | ZD |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 16.33B | 18.55B | 17.11B | 17.18B | 18.23B | |||||
Total Revenues | 16.33B | 18.55B | 17.11B | 17.18B | 18.23B | |||||
Cost of Goods Sold, Total | 14.49B | 16.74B | 16.02B | 15.51B | 16.38B | |||||
Gross Profit | 1.84B | 1.81B | 1.09B | 1.67B | 1.85B | |||||
Selling General & Admin Expenses, Total | 563M | 571M | 558M | 633M | 617M | |||||
Depreciation & Amortization - (IS) | 192M | 192M | 202M | 202M | 225M | |||||
Other Operating Expenses | 278M | 187M | 260M | 362M | 320M | |||||
Other Operating Expenses, Total | 1.03B | 949M | 1.02B | 1.2B | 1.16B | |||||
Operating Income | 808M | 856M | 66.81M | 478M | 684M | |||||
Interest Expense, Total | -18.48M | -17.15M | -23.74M | -36.06M | -23M | |||||
Interest And Investment Income | 3.61M | 7.19M | 11.47M | 19.19M | 19M | |||||
Net Interest Expenses | -14.86M | -9.96M | -12.28M | -16.86M | -4M | |||||
Income (Loss) On Equity Invest. | 24.48M | 18.44M | 16.69M | 20.93M | 2M | |||||
Other Non Operating Income (Expenses) | 7.25M | -887K | -4K | 13.02M | 0 | |||||
EBT, Excl. Unusual Items | 825M | 864M | 71.22M | 495M | 682M | |||||
Restructuring Charges | 14.36M | - | - | - | - | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | - | -8.66M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 8.58M | 38.56M | 57.28M | 38.6M | 53M | |||||
Asset Writedown | -20.36M | -19.54M | -16.96M | -10.3M | -8M | |||||
Insurance Settlements | - | 61.22M | 53.36M | - | - | |||||
Other Unusual Items | -1.98M | - | - | - | - | |||||
EBT, Incl. Unusual Items | 825M | 935M | 165M | 523M | 727M | |||||
Income Tax Expense | 212M | 220M | 23.76M | 107M | 188M | |||||
Earnings From Continuing Operations | 613M | 715M | 141M | 416M | 539M | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 613M | 715M | 141M | 416M | 539M | |||||
Minority Interest | -185K | -323K | -208K | -280K | - | |||||
Net Income - (IS) | 613M | 715M | 141M | 416M | 539M | |||||
Net Income to Common Incl Extra Items | 613M | 715M | 141M | 416M | 539M | |||||
Net Income to Common Excl. Extra Items | 613M | 715M | 141M | 416M | 539M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 14.03 | 16.37 | 3.23 | 9.53 | 12.35 | |||||
Basic EPS - Continuing Operations | 14.03 | 16.37 | 3.23 | 9.53 | 12.35 | |||||
Basic Weighted Average Shares Outstanding | 43.67M | 43.66M | 43.66M | 43.66M | 43.66M | |||||
Net EPS - Diluted | 14.03 | 16.37 | 3.23 | 9.53 | 12.34 | |||||
Diluted EPS - Continuing Operations | 14.03 | 16.37 | 3.23 | 9.53 | 12.34 | |||||
Diluted Weighted Average Shares Outstanding | 43.67M | 43.66M | 43.66M | 43.66M | 43.66M | |||||
Normalized Basic EPS | 11.8 | 12.36 | 1.01 | 7.07 | 9.76 | |||||
Normalized Diluted EPS | 11.8 | 12.36 | 1.01 | 7.07 | 9.76 | |||||
Dividend Per Share | 1.6 | 1.8 | 1.4 | 1.5 | 1.6 | |||||
Payout Ratio | 9.26 | 9.77 | 55.76 | 14.69 | 12.24 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 994M | 1.05B | 269M | 679M | 896M | |||||
EBITA | 826M | 871M | 82.15M | 487M | 694M | |||||
EBIT | 808M | 856M | 66.81M | 478M | 684M | |||||
EBITDAR | 1B | 1.06B | 278M | 691M | 899M | |||||
Effective Tax Rate - (Ratio) | 25.73 | 23.55 | 14.41 | 20.38 | 25.86 | |||||
Total Current Taxes | 94.05M | 85.05M | 86.33M | 76.53M | 91M | |||||
Total Deferred Taxes | 118M | 135M | -62.57M | 30.03M | 97M | |||||
Normalized Net Income | 515M | 539M | 44.31M | 309M | 426M | |||||
Interest Capitalized | 904K | 935K | - | - | - | |||||
Interest on Long-Term Debt | 1.93M | 1.84M | 1.84M | 1.99M | 2M | |||||
Non-Cash Pension Expense | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 11.59M | 11.76M | 11.85M | 13.53M | 14M | |||||
Net Rental Expense, Total | 8.81M | 9.07M | 9.6M | 11.93M | 3M | |||||
Imputed Operating Lease Interest Expense | 2.35M | 2.89M | 6.18M | 10.65M | 1.19M | |||||
Imputed Operating Lease Depreciation | 6.46M | 6.18M | 3.42M | 1.27M | 1.81M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 685K | 259K | 635K | 1.24M | 2M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 685K | 259K | 635K | 1.24M | 2M |
- Stock Market
- Stocks
- NDA Stock
- Financials Aurubis AG
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















